Replies to post #3042 on Arch Therapeutics Inc (ARTH)

[blackbandit]

wow, thx flash, do you realize what a cost savings this could be. In hemophilia and von wildebrons patients the docs have to administer blood clotting drugs before doing any kind of surgery, including dental. If AC5 replaces the need for that, then that's even more cost savings for patients and docs. I was already excited about ARTH, but even more so now.